Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medically Underserved Area | 1 | 2022 | 28 | 0.730 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 89 | 0.690 |
Why?
|
| Respiratory Protective Devices | 1 | 2020 | 13 | 0.670 |
Why?
|
| Mycosis Fungoides | 1 | 2019 | 3 | 0.630 |
Why?
|
| Ehrlichiosis | 1 | 2018 | 6 | 0.580 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2018 | 9 | 0.570 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 54 | 0.550 |
Why?
|
| Pandemics | 2 | 2021 | 672 | 0.520 |
Why?
|
| Coronary Artery Bypass | 2 | 2009 | 298 | 0.500 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2009 | 175 | 0.480 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 411 | 0.440 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2009 | 57 | 0.310 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2009 | 43 | 0.300 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 1556 | 0.260 |
Why?
|
| Aortic Valve Stenosis | 1 | 2009 | 188 | 0.260 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 981 | 0.240 |
Why?
|
| Heart Valve Diseases | 1 | 2007 | 95 | 0.240 |
Why?
|
| Internship and Residency | 2 | 2024 | 810 | 0.230 |
Why?
|
| Aortic Valve | 1 | 2007 | 190 | 0.230 |
Why?
|
| Hospital Medicine | 1 | 2023 | 6 | 0.210 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 316 | 0.200 |
Why?
|
| Humans | 14 | 2024 | 63607 | 0.200 |
Why?
|
| Postoperative Complications | 1 | 2009 | 1314 | 0.190 |
Why?
|
| Prescription Drug Monitoring Programs | 1 | 2021 | 1 | 0.180 |
Why?
|
| Prescription Drug Misuse | 1 | 2021 | 21 | 0.180 |
Why?
|
| Equipment Reuse | 1 | 2020 | 4 | 0.170 |
Why?
|
| Decontamination | 1 | 2020 | 13 | 0.170 |
Why?
|
| Masks | 1 | 2020 | 23 | 0.170 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 30 | 0.160 |
Why?
|
| RNA, Viral | 1 | 2021 | 276 | 0.160 |
Why?
|
| Ki-1 Antigen | 1 | 2019 | 1 | 0.160 |
Why?
|
| Dermatitis, Exfoliative | 1 | 2019 | 3 | 0.160 |
Why?
|
| Patient Admission | 1 | 2021 | 198 | 0.150 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 48 | 0.150 |
Why?
|
| Anaplasmosis | 1 | 2018 | 5 | 0.140 |
Why?
|
| Transaminases | 1 | 2018 | 14 | 0.140 |
Why?
|
| Patient Handoff | 1 | 2018 | 35 | 0.140 |
Why?
|
| Travel | 1 | 2018 | 42 | 0.140 |
Why?
|
| Fever | 1 | 2018 | 66 | 0.140 |
Why?
|
| Hospitals | 1 | 2021 | 394 | 0.140 |
Why?
|
| Inpatients | 1 | 2021 | 305 | 0.140 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 106 | 0.140 |
Why?
|
| Patient Transfer | 1 | 2018 | 93 | 0.140 |
Why?
|
| Emergency Service, Hospital | 3 | 2023 | 1106 | 0.140 |
Why?
|
| Middle Aged | 4 | 2024 | 17701 | 0.130 |
Why?
|
| Physicians | 1 | 2022 | 475 | 0.120 |
Why?
|
| Male | 5 | 2024 | 29988 | 0.120 |
Why?
|
| Retrospective Studies | 4 | 2021 | 6690 | 0.100 |
Why?
|
| Internal Medicine | 2 | 2024 | 160 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2009 | 147 | 0.080 |
Why?
|
| Physician-Patient Relations | 2 | 2024 | 421 | 0.080 |
Why?
|
| ROC Curve | 1 | 2009 | 282 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 376 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 422 | 0.070 |
Why?
|
| Reoperation | 1 | 2009 | 294 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 5493 | 0.070 |
Why?
|
| Communication | 2 | 2024 | 577 | 0.070 |
Why?
|
| Recurrence | 1 | 2009 | 642 | 0.070 |
Why?
|
| Emergency Treatment | 1 | 2007 | 58 | 0.060 |
Why?
|
| Aged | 3 | 2024 | 14511 | 0.060 |
Why?
|
| Comorbidity | 1 | 2009 | 1119 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1277 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2007 | 586 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2007 | 329 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1667 | 0.060 |
Why?
|
| Interior Design and Furnishings | 1 | 2024 | 3 | 0.050 |
Why?
|
| Baltimore | 1 | 2024 | 13 | 0.050 |
Why?
|
| Patients' Rooms | 1 | 2024 | 8 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1566 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2009 | 2081 | 0.050 |
Why?
|
| Prognosis | 1 | 2007 | 1748 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2464 | 0.040 |
Why?
|
| Female | 3 | 2024 | 33000 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2007 | 2576 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 700 | 0.040 |
Why?
|
| Controlled Before-After Studies | 1 | 2018 | 7 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2021 | 361 | 0.040 |
Why?
|
| Length of Stay | 1 | 2021 | 815 | 0.030 |
Why?
|
| United States | 2 | 2021 | 7867 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 316 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 3304 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 536 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2007 | 5705 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 710 | 0.030 |
Why?
|
| Massachusetts | 1 | 2021 | 2075 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2018 | 446 | 0.030 |
Why?
|
| Adult | 1 | 2024 | 16893 | 0.020 |
Why?
|